Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02847559
Title Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
Recruitment Suspended
Gender both
Phase Phase II
Variant Requirements No
Sponsors Northwestern University
Indications

meningioma

Therapies

Bevacizumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.